Form 4: Amgen EVP Jonathan P. Graham Reports Stock Disposal to Cover Tax Obligations

Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., disposed of 591 shares of common stock on May 2, 2024, to satisfy tax withholding obligations related to vested restricted stock units.

Summary

• On May 2, 2024, Jonathan P. Graham, EVP & General Counsel & Secretary of Amgen Inc., reported a transaction involving the disposal of 591 shares of Amgen common stock.
• The transaction was executed to cover tax obligations related to the vesting of restricted stock units (RSUs).
• Following the transaction, Graham directly owns 32,955 shares of Amgen common stock, which includes unvested RSUs and dividend equivalents (DEs).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't convey any particularly positive or negative sentiment about the company's prospects.

Future Outlook

The document does not contain any specific forward-looking statements regarding Amgen's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates that an executive disposed of shares to cover tax obligations, which is a common practice.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units (RSUs) as a way to align management's interests with those of shareholders.
• The vesting schedules and terms of these equity grants are generally comparable to those offered by other large pharmaceutical companies such as Pfizer (PFE), Johnson & Johnson (JNJ), and Merck (MRK).
• The disposal of shares to cover tax obligations is a standard practice among executives who receive equity compensation.

Stakeholder Impact

• The transaction itself is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates